SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-247828
Filing Date
2021-08-16
Accepted
2021-08-16 16:36:05
Documents
13
Period of Report
2021-08-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d147543d8k.htm   iXBRL 8-K 27682
2 EX-10.1 d147543dex101.htm EX-10.1 56222
  Complete submission text file 0001193125-21-247828.txt   223570

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA orgo-20210811.xsd EX-101.SCH 2520
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20210811_lab.xml EX-101.LAB 17971
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20210811_pre.xml EX-101.PRE 11237
6 EXTRACTED XBRL INSTANCE DOCUMENT d147543d8k_htm.xml XML 3578
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 211179008
SIC: 2834 Pharmaceutical Preparations